APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pathology Analysis System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Pathology Analysis System Market Outlook and Growth Opportunities 2026

2 May 2026196 pages

Choose your research edition.

Industry ResearchAI Pathology Analysis System Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pathology Analysis System Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI Pathology Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pathology Analysis System Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pathology Analysis System Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI Pathology Analysis System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Pathology Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Pathology Analysis System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Pathology Analysis System market include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte and Qritive, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Pathology Analysis System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Pathology Analysis System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Pathology Analysis System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Pathology Analysis System market.

AI Pathology Analysis System Segment by Company

Visiopharm

PathAI

Aiforia

Indica Labs

aetherAI

Proscia

Mindpeak

Techcyte

Qritive

Deepathology

Franklin.ai

Roche Diagnostics

Flagship

Dedalus Group

Ibex Medical Analytics

AI Pathology Analysis System Segment by Type

On-premises

Cloud-based

AI Pathology Analysis System Segment by Application

Hospital

Clinic

Others

AI Pathology Analysis System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Pathology Analysis System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Pathology Analysis System key companies, revenue, market share, and recent developments.

3. To split the AI Pathology Analysis System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Pathology Analysis System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Pathology Analysis System significant trends, drivers, influence factors in global and regions.

6. To analyze AI Pathology Analysis System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Analysis System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pathology Analysis System industry.

Chapter 3: Detailed analysis of AI Pathology Analysis System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Pathology Analysis System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Pathology Analysis System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Pathology Analysis System Industry Trends Table 2. AI Pathology Analysis System Industry Drivers Table 3. AI Pathology Analysis System Industry Opportunities and Challenges Table 4. AI Pathology Analysis System Industry Restraints Table 5. Global AI Pathology Analysis System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Pathology Analysis System Revenue Share by Company (2021-2026) Table 7. Global AI Pathology Analysis System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Pathology Analysis System Key Company Manufacturing Base & Headquarters Table 9. Global AI Pathology Analysis System Company, Product Type & Application Table 10. Global AI Pathology Analysis System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Pathology Analysis System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-premises Table 15. Significant Companies of Cloud-based Table 16. Global AI Pathology Analysis System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Pathology Analysis System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Pathology Analysis System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Pathology Analysis System Sales Value Share by Type (2021-2026) Table 20. Global AI Pathology Analysis System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global AI Pathology Analysis System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI Pathology Analysis System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global AI Pathology Analysis System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global AI Pathology Analysis System Sales Value Share by Application (2021-2026) Table 28. Global AI Pathology Analysis System Sales Value Share by Application (2027-2032) Table 29. Global AI Pathology Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI Pathology Analysis System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global AI Pathology Analysis System Sales Value Share by Region (2021-2026) Table 32. Global AI Pathology Analysis System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global AI Pathology Analysis System Sales Value Share by Region (2027-2032) Table 34. Global AI Pathology Analysis System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global AI Pathology Analysis System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global AI Pathology Analysis System Sales Value Market Share by Country (2021-2026) Table 37. Global AI Pathology Analysis System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global AI Pathology Analysis System Sales Value Market Share by Country (2027-2032) Table 39. Visiopharm Company Information Table 40. Visiopharm Business Overview Table 41. Visiopharm AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Visiopharm AI Pathology Analysis System Product Portfolio Table 43. Visiopharm Recent Development Table 44. PathAI Company Information Table 45. PathAI Business Overview Table 46. PathAI AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. PathAI AI Pathology Analysis System Product Portfolio Table 48. PathAI Recent Development Table 49. Aiforia Company Information Table 50. Aiforia Business Overview Table 51. Aiforia AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Aiforia AI Pathology Analysis System Product Portfolio Table 53. Aiforia Recent Development Table 54. Indica Labs Company Information Table 55. Indica Labs Business Overview Table 56. Indica Labs AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Indica Labs AI Pathology Analysis System Product Portfolio Table 58. Indica Labs Recent Development Table 59. aetherAI Company Information Table 60. aetherAI Business Overview Table 61. aetherAI AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. aetherAI AI Pathology Analysis System Product Portfolio Table 63. aetherAI Recent Development Table 64. Proscia Company Information Table 65. Proscia Business Overview Table 66. Proscia AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Proscia AI Pathology Analysis System Product Portfolio Table 68. Proscia Recent Development Table 69. Mindpeak Company Information Table 70. Mindpeak Business Overview Table 71. Mindpeak AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Mindpeak AI Pathology Analysis System Product Portfolio Table 73. Mindpeak Recent Development Table 74. Techcyte Company Information Table 75. Techcyte Business Overview Table 76. Techcyte AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Techcyte AI Pathology Analysis System Product Portfolio Table 78. Techcyte Recent Development Table 79. Qritive Company Information Table 80. Qritive Business Overview Table 81. Qritive AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Qritive AI Pathology Analysis System Product Portfolio Table 83. Qritive Recent Development Table 84. Deepathology Company Information Table 85. Deepathology Business Overview Table 86. Deepathology AI Pathology Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Deepathology AI Pathology Analysis System Product Portfolio Table 88. Deepathology Recent Development Table 89. Franklin.ai Company Information Table 90. Franklin.ai Business Overview Table 91. Franklin.ai AI Pathology Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Franklin.ai AI Pathology Analysis System Product Portfolio Table 93. Franklin.ai Recent Development Table 94. Roche Diagnostics Company Information Table 95. Roche Diagnostics Business Overview Table 96. Roche Diagnostics AI Pathology Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Roche Diagnostics AI Pathology Analysis System Product Portfolio Table 98. Roche Diagnostics Recent Development Table 99. Flagship Company Information Table 100. Flagship Business Overview Table 101. Flagship AI Pathology Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Flagship AI Pathology Analysis System Product Portfolio Table 103. Flagship Recent Development Table 104. Dedalus Group Company Information Table 105. Dedalus Group Business Overview Table 106. Dedalus Group AI Pathology Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Dedalus Group AI Pathology Analysis System Product Portfolio Table 108. Dedalus Group Recent Development Table 109. Ibex Medical Analytics Company Information Table 110. Ibex Medical Analytics Business Overview Table 111. Ibex Medical Analytics AI Pathology Analysis System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Ibex Medical Analytics AI Pathology Analysis System Product Portfolio Table 113. Ibex Medical Analytics Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. AI Pathology Analysis System Product Image Figure 2. Global AI Pathology Analysis System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Pathology Analysis System Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Pathology Analysis System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-premises Image Figure 8. Cloud-based Image Figure 9. Global AI Pathology Analysis System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Pathology Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Pathology Analysis System Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global AI Pathology Analysis System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global AI Pathology Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global AI Pathology Analysis System Sales Value Share by Application (2021-2032) Figure 18. Global AI Pathology Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global AI Pathology Analysis System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America AI Pathology Analysis System Sales Value (2021-2032) & (US$ Million) Figure 21. North America AI Pathology Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe AI Pathology Analysis System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe AI Pathology Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific AI Pathology Analysis System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific AI Pathology Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America AI Pathology Analysis System Sales Value (2021-2032) & (US$ Million) Figure 27. South America AI Pathology Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa AI Pathology Analysis System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa AI Pathology Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt AI Pathology Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • On-premises
  • Cloud-based
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Visiopharm
  • PathAI
  • Aiforia
  • Indica Labs
  • aetherAI
  • Proscia
  • Mindpeak
  • Techcyte
  • Qritive
  • Deepathology
  • Franklin.ai
  • Roche Diagnostics
  • Flagship
  • Dedalus Group
  • Ibex Medical Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Pathology Analysis System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Pathology Analysis System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Pathology Analysis System Market Dynamics
  1. 2.1 AI Pathology Analysis System Industry Trends
  2. 2.2 AI Pathology Analysis System Industry Drivers
  3. 2.3 AI Pathology Analysis System Industry Opportunities and Challenges
  4. 2.4 AI Pathology Analysis System Industry Restraints
3 AI Pathology Analysis System Market by Company
  1. 3.1 Global AI Pathology Analysis System Company Revenue Ranking in 2025
  2. 3.2 Global AI Pathology Analysis System Revenue by Company (2021-2026)
  3. 3.3 Global AI Pathology Analysis System Company Ranking (2024-2026)
  4. 3.4 Global AI Pathology Analysis System Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Pathology Analysis System Company Product Type and Application
  6. 3.6 Global AI Pathology Analysis System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Pathology Analysis System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Pathology Analysis System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Pathology Analysis System Market by Type
  1. 4.1 AI Pathology Analysis System Type Introduction
  2. 4.1.1 On-premises
  3. 4.1.2 Cloud-based
  4. 4.2 Global AI Pathology Analysis System Sales Value by Type
  5. 4.2.1 Global AI Pathology Analysis System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Pathology Analysis System Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Pathology Analysis System Sales Value Share by Type (2021-2032)
5 AI Pathology Analysis System Market by Application
  1. 5.1 AI Pathology Analysis System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global AI Pathology Analysis System Sales Value by Application
  6. 5.2.1 Global AI Pathology Analysis System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Pathology Analysis System Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Pathology Analysis System Sales Value Share by Application (2021-2032)
6 AI Pathology Analysis System Regional Value Analysis
  1. 6.1 Global AI Pathology Analysis System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Pathology Analysis System Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Pathology Analysis System Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Pathology Analysis System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Pathology Analysis System Sales Value (2021-2032)
  7. 6.3.2 North America AI Pathology Analysis System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Pathology Analysis System Sales Value (2021-2032)
  10. 6.4.2 Europe AI Pathology Analysis System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Pathology Analysis System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Pathology Analysis System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Pathology Analysis System Sales Value (2021-2032)
  16. 6.6.2 South America AI Pathology Analysis System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Pathology Analysis System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Pathology Analysis System Sales Value Share by Country, 2025 VS 2032
7 AI Pathology Analysis System Country-level Value Analysis
  1. 7.1 Global AI Pathology Analysis System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Pathology Analysis System Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Pathology Analysis System Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Pathology Analysis System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Pathology Analysis System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Pathology Analysis System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Pathology Analysis System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Visiopharm
  2. 8.1.1 Visiopharm Company Information
  3. 8.1.2 Visiopharm Business Overview
  4. 8.1.3 Visiopharm AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Visiopharm AI Pathology Analysis System Product Portfolio
  6. 8.1.5 Visiopharm Recent Developments
  7. 8.2 PathAI
  8. 8.2.1 PathAI Company Information
  9. 8.2.2 PathAI Business Overview
  10. 8.2.3 PathAI AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PathAI AI Pathology Analysis System Product Portfolio
  12. 8.2.5 PathAI Recent Developments
  13. 8.3 Aiforia
  14. 8.3.1 Aiforia Company Information
  15. 8.3.2 Aiforia Business Overview
  16. 8.3.3 Aiforia AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aiforia AI Pathology Analysis System Product Portfolio
  18. 8.3.5 Aiforia Recent Developments
  19. 8.4 Indica Labs
  20. 8.4.1 Indica Labs Company Information
  21. 8.4.2 Indica Labs Business Overview
  22. 8.4.3 Indica Labs AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Indica Labs AI Pathology Analysis System Product Portfolio
  24. 8.4.5 Indica Labs Recent Developments
  25. 8.5 aetherAI
  26. 8.5.1 aetherAI Company Information
  27. 8.5.2 aetherAI Business Overview
  28. 8.5.3 aetherAI AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 aetherAI AI Pathology Analysis System Product Portfolio
  30. 8.5.5 aetherAI Recent Developments
  31. 8.6 Proscia
  32. 8.6.1 Proscia Company Information
  33. 8.6.2 Proscia Business Overview
  34. 8.6.3 Proscia AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Proscia AI Pathology Analysis System Product Portfolio
  36. 8.6.5 Proscia Recent Developments
  37. 8.7 Mindpeak
  38. 8.7.1 Mindpeak Company Information
  39. 8.7.2 Mindpeak Business Overview
  40. 8.7.3 Mindpeak AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mindpeak AI Pathology Analysis System Product Portfolio
  42. 8.7.5 Mindpeak Recent Developments
  43. 8.8 Techcyte
  44. 8.8.1 Techcyte Company Information
  45. 8.8.2 Techcyte Business Overview
  46. 8.8.3 Techcyte AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Techcyte AI Pathology Analysis System Product Portfolio
  48. 8.8.5 Techcyte Recent Developments
  49. 8.9 Qritive
  50. 8.9.1 Qritive Company Information
  51. 8.9.2 Qritive Business Overview
  52. 8.9.3 Qritive AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qritive AI Pathology Analysis System Product Portfolio
  54. 8.9.5 Qritive Recent Developments
  55. 8.10 Deepathology
  56. 8.10.1 Deepathology Company Information
  57. 8.10.2 Deepathology Business Overview
  58. 8.10.3 Deepathology AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Deepathology AI Pathology Analysis System Product Portfolio
  60. 8.10.5 Deepathology Recent Developments
  61. 8.11 Franklin.ai
  62. 8.11.1 Franklin.ai Company Information
  63. 8.11.2 Franklin.ai Business Overview
  64. 8.11.3 Franklin.ai AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Franklin.ai AI Pathology Analysis System Product Portfolio
  66. 8.11.5 Franklin.ai Recent Developments
  67. 8.12 Roche Diagnostics
  68. 8.12.1 Roche Diagnostics Company Information
  69. 8.12.2 Roche Diagnostics Business Overview
  70. 8.12.3 Roche Diagnostics AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Roche Diagnostics AI Pathology Analysis System Product Portfolio
  72. 8.12.5 Roche Diagnostics Recent Developments
  73. 8.13 Flagship
  74. 8.13.1 Flagship Company Information
  75. 8.13.2 Flagship Business Overview
  76. 8.13.3 Flagship AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Flagship AI Pathology Analysis System Product Portfolio
  78. 8.13.5 Flagship Recent Developments
  79. 8.14 Dedalus Group
  80. 8.14.1 Dedalus Group Company Information
  81. 8.14.2 Dedalus Group Business Overview
  82. 8.14.3 Dedalus Group AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dedalus Group AI Pathology Analysis System Product Portfolio
  84. 8.14.5 Dedalus Group Recent Developments
  85. 8.15 Ibex Medical Analytics
  86. 8.15.1 Ibex Medical Analytics Company Information
  87. 8.15.2 Ibex Medical Analytics Business Overview
  88. 8.15.3 Ibex Medical Analytics AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ibex Medical Analytics AI Pathology Analysis System Product Portfolio
  90. 8.15.5 Ibex Medical Analytics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst